Cable One, Inc. (CABO)
Live price chart, market sentiment, and community perspectives for Cable One, Inc. (NYSE: CABO).
Live price chart, market sentiment, and community perspectives for Cable One, Inc. (NYSE: CABO).
On our macro equity desk, CABO looks like a textbook casualty of secular cord-cutting and intense local fiber competition. Seeing Q2 2026 revenue drop 8.4% year-over-year to $348.9 million alongside a net loss of over $1.16 billion highlights severe structural headwinds. Even with management pushing targeted pricing and speed upgrades, the loss of 17,000 residential broadband customers this quarter shows churn is winning the battle.
Looking at the balance sheet and cash flow metrics, Adjusted EBITDA dropped to $173.5 million with free cash flow contracting to $99.5 million. The stock trading near its 52-week lows around $28 with a trailing negative EPS underscores deep market skepticism. Pending moves like the MBI acquisition might increase leverage risks rather than solve top-line erosion.
From a quantitative risk perspective, the technical breakdown is brutal. With a 52-week range bottoming out near $27 and a trailing P/E of -0.5, volatility parameters are extremely stretched. We are advising caution against bottom-fishing until broadband churn stabilizes and residential data revenue shows consecutive quarter-over-quarter growth rather than ongoing declines.
As a hedge fund portfolio manager evaluating telecom assets, CABO's bull case relies almost entirely on whether their multi-gigabit infrastructure rollout and mobile service pilot can successfully alter customer retention. However, with business data revenue also falling due to divested tower contracts, the turnaround timeline looks extended and fraught with execution risk.
Reviewing the sell-side consensus and recent earnings call transcripts, management is leaning heavily into digital and direct-sales channels. While early adoption of their mobile offering is encouraging, it remains a drop in the bucket compared to the heavy broadband subscriber bleeding caused by aggressive fiber overbuilders in their markets.
Explore plasma cleansing, somatic organ swaps, and BCI.